glutamine has been researched along with Skin Neoplasms in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 13 (68.42) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Amos, CI; Bloomer, W; Chen, K; Lee, JE; Li, X; Liu, H; Liu, Z; Nan, H; Wei, Q | 1 |
| Bacci, M; Corsini, M; Grillo, E; Mitola, S; Monti, E; Morandi, A; Presta, M; Ravelli, C; Zammataro, L | 1 |
| Luan, W; Wang, J; Xia, Y; Xu, B; Zhou, Z; Zhu, Y | 1 |
| Agostinis, P; Maes, H; Van Dingenen, S; Vara-Perez, M | 1 |
| Bonneu, M; Bouzier-Sore, AK; Claverol, S; Douki, T; Dousset, L; Hosseini, M; Ivanovic, Z; Kasraian, Z; Mahfouf, W; Mesli, S; Obre, E; Rachidi, W; Redonnet-Vernhet, I; Rezvani, HR; Rossignol, R; Serrano-Sanchez, M; Taieb, A; Vlaski, M | 1 |
| Gomez, GVB; Lima, CSP; Lourenço, GJ; Moraes, AM; Oliveira, C; Rinck-Junior, JA; Torricelli, C | 1 |
| Bailey, CG; Beaumont, KA; Font, J; Haass, NK; Holst, J; Jormakka, M; Otte, NJ; Rasko, JE; Ryan, RM; Sharp, DM; Tiffen, JC; van Geldermalsen, M; Wang, Q | 1 |
| Alaibac, M; Frigo, AC; Michelotto, A; Piaserico, S | 1 |
| Osterman, AL; Ratnikov, BI; Ronai, ZA; Scott, DA; Smith, JW | 1 |
| Nickoloff, BJ; Qin, JZ; Xin, H | 1 |
| Garcia, A; Lyng, F; Murphy, JE; Walsh, J; Zanchetta, LM | 1 |
| Adam, J; Chaneton, B; Deberardinis, RJ; Folger, O; Frezza, C; Gottlieb, E; Hedley, A; Jerby, L; Kalna, G; MacKenzie, ED; Micaroni, M; Pollard, PJ; Rajagopalan, KN; Ruppin, E; Shlomi, T; Tomlinson, IP; Watson, DG; Zheng, L | 1 |
| Chiang, GG; Filipp, FV; Knutzen, CA; Osterman, AL; Richardson, AD; Ronai, ZA; Scott, DA; Smith, JW | 1 |
| De Ingeniis, J; Filipp, FV; Osterman, AL; Ratnikov, B; Scott, DA; Smith, JW | 1 |
| Asensi, M; Benlloch, M; Brown, BD; Carretero, J; Estrela, JM; Mena, S; Obrador, E; Ortega, A; Petschen, I | 1 |
| Bermejo, JL; Gurzau, E; Hemminki, K; Koppova, K; Kumar, R; Rudnai, P; Scherer, D | 1 |
| Bhattacharya, P; Chakraborty, S; Maity, P | 1 |
| Abramson, A; Lin, YJ; Stamberg, J; Steinberg, BM; Zaslav, AL | 1 |
| da Fonseca-Wollheim, F; Liss, E; Reinecke, A | 1 |
2 review(s) available for glutamine and Skin Neoplasms
| Article | Year |
|---|---|
Metabolic rewiring in melanoma.
Topics: Antineoplastic Agents; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Glutamine; Glycolysis; GTP Phosphohydrolases; Humans; MAP Kinase Signaling System; Melanoma; Membrane Proteins; Mutation; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Tumor Microenvironment | 2017 |
Glutamine-fueled mitochondrial metabolism is decoupled from glycolysis in melanoma.
Topics: Citric Acid Cycle; Glutamine; Glycolysis; Humans; Melanoma; Mitochondria; Skin Neoplasms | 2012 |
17 other study(ies) available for glutamine and Skin Neoplasms
| Article | Year |
|---|---|
Genetic variants in glutamine metabolic pathway genes predict cutaneous melanoma-specific survival.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Glutamine; Histidine Ammonia-Lyase; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Metabolic Networks and Pathways; Middle Aged; Polymorphism, Single Nucleotide; Pyrroline Carboxylate Reductases; Skin Neoplasms | 2019 |
Expression of activated VEGFR2 by R1051Q mutation alters the energy metabolism of Sk-Mel-31 melanoma cells by increasing glutamine dependence.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Cell Line, Tumor; Energy Metabolism; Enzyme Inhibitors; Gain of Function Mutation; Glutaminase; Glutamine; Humans; Melanoma; Signal Transduction; Skin Neoplasms; Vascular Endothelial Growth Factor Receptor-2 | 2021 |
miR-137 inhibits glutamine catabolism and growth of malignant melanoma by targeting glutaminase.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Glutaminase; Glutamine; Heterografts; Humans; Melanoma; Mice; Mice, Nude; MicroRNAs; Prognosis; Skin Neoplasms | 2018 |
BNIP3 contributes to the glutamine-driven aggressive behavior of melanoma cells.
Topics: Cell Line, Tumor; Cell Proliferation; Energy Metabolism; Gene Silencing; Glutamine; Humans; Melanoma; Membrane Proteins; Neoplasm Metastasis; Proto-Oncogene Proteins; Skin Neoplasms | 2019 |
Energy Metabolism Rewiring Precedes UVB-Induced Primary Skin Tumor Formation.
Topics: Animals; Carcinogenesis; Dihydroorotate Dehydrogenase; DNA-Binding Proteins; Down-Regulation; Electron Transport; Energy Metabolism; Epidermis; Glutamine; High Mobility Group Proteins; Keratinocytes; Metabolic Networks and Pathways; Mice; Mice, Hairless; Oxidoreductases Acting on CH-CH Group Donors; Phenotype; Skin Neoplasms; Ultraviolet Rays; Up-Regulation | 2018 |
Influence of functional variants Asp312Asn and Lys751Gln of Xeroderma Pigmentosum Group D (XPD) and Glutathione S-transferase Mu 1 (GSTM1) and Theta 1 (GSTT1) genes on cutaneous melanoma susceptibility and prognosis.
Topics: Aged; Asparagine; Aspartic Acid; Cell Survival; Disease-Free Survival; Genetic Predisposition to Disease; Genetic Variation; Genotype; Glutamine; Glutathione Transferase; Humans; Lysine; Melanoma; Middle Aged; Prognosis; Proportional Hazards Models; Skin Neoplasms; Treatment Outcome; Xeroderma Pigmentosum | 2019 |
Targeting glutamine transport to suppress melanoma cell growth.
Topics: Amino Acid Transport System ASC; Amino Acids, Cyclic; Benzyl Compounds; Biological Transport; Carrier Proteins; CDC2 Protein Kinase; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; Glutamine; Humans; Large Neutral Amino Acid-Transporter 1; Leucine; Mechanistic Target of Rapamycin Complex 1; Melanoma; Minor Histocompatibility Antigens; Multiprotein Complexes; Proto-Oncogene Proteins B-raf; RNA Interference; RNA, Small Interfering; Serine; Signal Transduction; Skin Neoplasms; Spheroids, Cellular; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Ubiquitin-Conjugating Enzymes | 2014 |
TLR7 Gln11Leu single nucleotide polymorphism and response to treatment with imiquimod in patients with basal cell carcinoma: a pilot study.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Resistance, Neoplasm; Female; Glutamine; Humans; Imiquimod; Leucine; Male; Pilot Projects; Polymorphism, Single Nucleotide; Skin Neoplasms; Toll-Like Receptor 7; Treatment Outcome | 2015 |
Targeting glutamine metabolism sensitizes melanoma cells to TRAIL-induced death.
Topics: Aminooxyacetic Acid; Apoptosis; Cell Line, Tumor; Drug Resistance, Neoplasm; Enzyme Inhibitors; Fibroblasts; Glutamine; Humans; Melanocytes; Melanoma; Receptors, Death Domain; Skin Neoplasms; TNF-Related Apoptosis-Inducing Ligand | 2010 |
Mitophagy and mitochondrial morphology in human melanoma-derived cells post exposure to simulated sunlight.
Topics: Autophagy; Cell Line, Tumor; Glutamine; Humans; Lysosomes; Melanins; Melanoma; Microscopy, Confocal; Mitochondria; Models, Biological; Signal Transduction; Skin; Skin Neoplasms; Sunlight; Ultraviolet Rays | 2011 |
Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase.
Topics: Animals; Bilirubin; Cell Line; Cells, Cultured; Citric Acid Cycle; Computer Simulation; Fumarate Hydratase; Fumarates; Genes, Lethal; Genes, Tumor Suppressor; Glutamine; Heme; Heme Oxygenase (Decyclizing); Kidney Neoplasms; Leiomyomatosis; Mice; Mitochondria; Mutation; NAD; Neoplastic Syndromes, Hereditary; Skin Neoplasms; Uterine Neoplasms | 2011 |
Comparative metabolic flux profiling of melanoma cell lines: beyond the Warburg effect.
Topics: Cell Line, Tumor; Citric Acid Cycle; Fermentation; Gas Chromatography-Mass Spectrometry; Glucose; Glutamine; Glycolysis; Humans; Hypoxia; Ketoglutaric Acids; Lactic Acid; Melanocytes; Melanoma; Models, Biological; Skin Neoplasms | 2011 |
Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease.
Topics: Animals; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Glutamine; Glutathione; Melanoma, Experimental; Mice; Neoplasm Metastasis; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Skin Neoplasms; Thionucleotides; Treatment Outcome; Tumor Necrosis Factor-alpha; X-Rays | 2007 |
MC1R variants associated susceptibility to basal cell carcinoma of skin: interaction with host factors and XRCC3 polymorphism.
Topics: Adult; Aged; Arginine; Carcinoma, Basal Cell; Case-Control Studies; DNA-Binding Proteins; Female; Genetic Predisposition to Disease; Genotype; Glutamine; Humans; Hungary; Male; Methionine; Middle Aged; Polymorphism, Genetic; Receptor, Melanocortin, Type 1; Risk Factors; Romania; Sequence Analysis, DNA; Skin Neoplasms; Slovakia; Threonine | 2008 |
A general survey of glutamine level in different tissues of murine solid tumor bearing mice before and after therapy with purified glutaminase.
Topics: Animals; Brain; Carcinoma, Ehrlich Tumor; Glutaminase; Glutamine; Intestinal Mucosa; Kidney; Liver; Male; Methylcholanthrene; Mice; Sarcoma 180; Skin Neoplasms; Spleen; Tissue Distribution | 2000 |
Cytogenetic analysis of head and neck carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chromosome Aberrations; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 13; Chromosomes, Human, Pair 14; Female; Glutamine; Head and Neck Neoplasms; Humans; Male; Middle Aged; Skin Neoplasms; Tumor Cells, Cultured | 1991 |
[Effect of glutamine on the incorporation of ( 14 C)leucine into protein and of ( 3 H)thymidine into DNA of Yoshida ascites tumor cells].
Topics: Adenosine Triphosphate; Animals; Carbon Isotopes; Cell Line; DNA, Neoplasm; Female; Glutamine; Leucine; Mice; Mice, Inbred Strains; Neoplasm Proteins; Neoplasms, Experimental; RNA, Neoplasm; Sarcoma, Yoshida; Skin Neoplasms; Thymidine; Time Factors; Tritium | 1972 |